C5 Acquisition extends deadline to Dec 31, 2023; ~$202.7M redeemed, trust drops to ~$96.9M

C5 Acquisition Corp

Shareholders approved charter amendment extending business combination deadline from April 11, 2023 to Dec 31, 2023.
Holders of 19,455,692 shares redeemed at ~$10.42/share, aggregate ~$202.7M removed from trust.
After redemptions, ~9.3M shares remain outstanding and ~$96.9M in trust.
Sponsor will make monthly deposits of $320k to trust starting April 11, 2023, via non-interest promissory note.
Votes: 27,069,195 for, 589,801 against, 54,892 abstain.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

C5 Acquisition Corp: Extended the deadline to consummate a business combination from April 11, 2023 to December 31, 2023 (effective 2023-04-06).

Change: charter amendment
Effective: 2023-04-06

Exact text from the filing

The Company filed the Charter Amendment with the Secretary of State of the State of Delaware on April 6, 2023.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

C5 Acquisition Corp shareholders approved Adopt the Charter Amendment at the 2023-04-06 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2023-04-06

Exact text from the filing

The stockholders of the Company (the “Stockholders”) voted on the proposal to adopt the Charter Amendment, which is described in more detail in the definitive proxy statement of the Company filed with the Securities and Exchange Commission (the “SEC”) on March 16, 2023 (the “Proxy Statement”). The final voting results for the Charter Amendment were as follows: For Against Abstain 27,069,195 589,801 54,892

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0000950142-23-001030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.